Disrupted nighttime sleep and sleep instability in narcolepsy.

disrupted nighttime sleep narcolepsy orexin/hypocretin polysomnography sleep instability

Journal

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
ISSN: 1550-9397
Titre abrégé: J Clin Sleep Med
Pays: United States
ID NLM: 101231977

Informations de publication

Date de publication:
01 01 2022
Historique:
pubmed: 1 9 2021
medline: 19 2 2022
entrez: 31 8 2021
Statut: ppublish

Résumé

This review aimed to summarize current knowledge about disrupted nighttime sleep (DNS) and sleep instability in narcolepsy, including self-reported and objective assessments, potential causes of sleep instability, health consequences and functional burden, and management. One hundred two peer-reviewed publications from a PubMed search were included. DNS is a key symptom of narcolepsy but has received less attention than excessive daytime sleepiness and cataplexy. There has been a lack of clarity regarding the definition of DNS, as many sleep-related symptoms and conditions disrupt sleep quality in narcolepsy (eg, hallucinations, sleep paralysis, rapid eye movement sleep behavior disorder, nightmares, restless legs syndrome/periodic leg movements, nocturnal eating, sleep apnea, depression, anxiety). In addition, the intrinsic sleep instability of narcolepsy results in frequent spontaneous wakings and sleep stage transitions, contributing to DNS. Sleep instability likely emerges in the setting of orexin insufficiency/deficiency, but its exact pathophysiology remains unknown. DNS impairs quality of life among people with narcolepsy, and more research is needed to determine its contributions to cardiovascular risk. Multimodal treatment is appropriate for DNS management, including behavioral therapies, counseling on sleep hygiene, and/or medication. There is strong evidence showing improvement in self-reported sleep quality and objective sleep stability measures with sodium oxybate, but rigorous clinical trials with other pharmacotherapies are needed. Treatment may be complicated by comorbidities, concomitant medications, and mood disorders. DNS is a common symptom of narcolepsy deserving consideration in clinical care and future research. Maski K, Mignot E, Plazzi G, Dauvilliers Y. Disrupted nighttime sleep and sleep instability in narcolepsy.

Identifiants

pubmed: 34463249
pii: jcsm.9638
doi: 10.5664/jcsm.9638
pmc: PMC8807887
doi:

Substances chimiques

Sodium Oxybate 7G33012534

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

289-304

Subventions

Organisme : NINDS NIH HHS
ID : K23 NS104267
Pays : United States

Informations de copyright

© 2022 American Academy of Sleep Medicine.

Références

Sleep. 1993 Aug;16(5):444-56
pubmed: 8378686
Sleep. 2014 Mar 01;37(3):439-44
pubmed: 24587565
Sleep. 2011 May 01;34(5):601-8
pubmed: 21532953
PLoS One. 2012;7(6):e38977
pubmed: 22768053
Front Neurol. 2018 Aug 24;9:707
pubmed: 30197622
Sleep. 2006 Sep;29(9):1155-73
pubmed: 17040003
Sleep Med. 2014 May;15(5):502-7
pubmed: 24780133
J Sleep Res. 2003 Mar;12(1):63-71
pubmed: 12603788
PLoS One. 2014 Mar 20;9(3):e91982
pubmed: 24651580
Sleep. 2006 Jul;29(7):939-46
pubmed: 16895262
J Clin Sleep Med. 2013 May 15;9(5):499-500
pubmed: 23674942
Pediatrics. 2019 Oct;144(4):
pubmed: 31570648
Nat Commun. 2018 Dec 6;9(1):5229
pubmed: 30523329
Sleep Med. 2018 Dec;52:88-91
pubmed: 30286385
J Clin Sleep Med. 2010 Dec 15;6(6):596-602
pubmed: 21206549
J Clin Sleep Med. 2013 Sep 15;9(9):955-65
pubmed: 23997709
Sleep. 2013 Jan 01;36(1):91-8
pubmed: 23288975
Front Neurol. 2021 Mar 04;12:629709
pubmed: 33746882
Nurs Res. 1993 Mar-Apr;42(2):111-7
pubmed: 8455986
Sleep. 2016 May 01;39(5):1047-50
pubmed: 26856902
Pharmacopsychiatry. 2003 Jul;36(4):150-5
pubmed: 12905101
Med Sci Sports Exerc. 2019 Jul;51(7):1538-1557
pubmed: 30789439
Gen Hosp Psychiatry. 1990 May;12(3):191-7
pubmed: 2335305
Ann Neurol. 2013 Dec;74(6):794-804
pubmed: 24006291
Sleep Med. 2017 Dec;40:53-57
pubmed: 29221779
Environ Int. 2019 Mar;124:66-78
pubmed: 30640131
Sleep. 2020 Jun 15;43(6):
pubmed: 31993661
Sleep. 2008 Jun;31(6):859-67
pubmed: 18548831
Pediatrics. 2015 Dec;136(6):1144-53
pubmed: 26598454
Trends Neurosci. 2001 Dec;24(12):726-31
pubmed: 11718878
Am Health Drug Benefits. 2017 Jul;10(5):233-241
pubmed: 28975007
Sleep Med. 2017 May;33:13-18
pubmed: 28449892
Brain. 2013 Dec;136(Pt 12):3787-95
pubmed: 24142146
J Clin Sleep Med. 2005 Oct 15;1(4):391-7
pubmed: 17564408
Neurology. 2020 Nov 24;95(21):e2900-e2911
pubmed: 32873687
Curr Med Res Opin. 2006 Apr;22(4):761-74
pubmed: 16684437
Pediatr Neurol. 2009 Jul;41(1):9-16
pubmed: 19520267
CNS Neurosci Ther. 2013 Jul;19(7):521-8
pubmed: 23574649
J Clin Sleep Med. 2018 Jan 15;14(1):65-74
pubmed: 29198301
J Sleep Res. 2011 Dec;20(4):514-21
pubmed: 21261767
Sleep. 2007 Dec;30(12):1705-11
pubmed: 18246980
Sleep. 1991 Apr;14(2):130-2
pubmed: 1678203
Sleep. 1992 Jun;15(3):212-6
pubmed: 1621021
J Hypertens. 2002 Nov;20(11):2183-9
pubmed: 12409956
Eur J Neurol. 2006 Oct;13(10):1035-48
pubmed: 16987156
Sleep Med. 2014 Feb;15(2):262-5
pubmed: 24468101
Neurology. 2017 Apr 4;88(14):1358-1365
pubmed: 28258080
J Sleep Res. 2012 Apr;21(2):155-62
pubmed: 21827556
Sleep Med. 2009 Sep;10(8):829-35
pubmed: 19616998
Sleep. 2007 Jul;30(7):844-9
pubmed: 17682654
Sleep. 1993 Jun;16(4):306-17
pubmed: 8341891
Acta Neurobiol Exp (Wars). 2017;77(2):147-156
pubmed: 28691719
Nat Rev Neurol. 2019 Sep;15(9):519-539
pubmed: 31324898
J Neurol Neurosurg Psychiatry. 1996 May;60(5):576-8
pubmed: 8778267
Biol Psychiatry. 2016 Jan 15;79(2):136-48
pubmed: 25526970
J Clin Psychiatry. 2017 Feb;78(2):171-176
pubmed: 27835717
Sleep Med. 2015 Jan;16(1):126-30
pubmed: 25547035
Sleep. 2019 Dec 24;42(12):
pubmed: 31353416
Sleep. 2013 Jun 01;36(6):835-40
pubmed: 23729926
Neuron. 2010 Dec 22;68(6):1023-42
pubmed: 21172606
Sleep Med. 2010 Jan;11(1):93-5
pubmed: 19699146
Sleep Med. 2000 Feb 1;1(1):33-39
pubmed: 10733618
Eur J Neurol. 2012 May;19(5):696-702
pubmed: 22182320
J Clin Sleep Med. 2013 Jul 15;9(7):675-80
pubmed: 23853561
Sleep Med Rev. 2011 Aug;15(4):259-67
pubmed: 21237680
Sleep. 2009 Feb;32(2):181-7
pubmed: 19238805
Sleep Med. 2015 Dec;16(12):1516-27
pubmed: 26611950
Cell. 1999 Aug 20;98(4):437-51
pubmed: 10481909
Sleep. 2012 Sep 01;35(9):1247-55F
pubmed: 22942503
J Clin Sleep Med. 2017 Mar 15;13(3):419-425
pubmed: 27923434
Sleep. 2013 Aug 01;36(8):1173-7
pubmed: 23904677
Clin Neurophysiol. 2016 Aug;127(8):2812-2819
pubmed: 27417057
Pediatr Neurol. 2019 Apr;93:39-42
pubmed: 30595352
Sleep. 2015 Aug 01;38(8):1277-84
pubmed: 25845690
J Sleep Res. 2017 Aug;26(4):407-414
pubmed: 27807903
Brain. 2010 Feb;133(Pt 2):568-79
pubmed: 20129934
Sleep. 2021 May 14;44(5):
pubmed: 33249455
Brain. 2017 Jun 1;140(6):1669-1679
pubmed: 28472332
Sleep. 1991 Dec;14(6):540-5
pubmed: 1798888
Sleep. 2012 Apr 01;35(4):519-28
pubmed: 22467990
Sleep. 2020 Oct 13;43(10):
pubmed: 32253429
Sleep. 2018 Jun 1;41(6):
pubmed: 29522206
J Sleep Res. 2000 Sep;9(3):309-16
pubmed: 11012872
J Clin Sleep Med. 2018 Feb 15;14(2):245-252
pubmed: 29351827
J Clin Sleep Med. 2013 Aug 15;9(8):805-12
pubmed: 23946711
Sleep. 2016 Feb 01;39(2):369-77
pubmed: 26446125
Sleep. 2016 Jun 01;39(6):1241-7
pubmed: 27091539
Sleep. 2012 Oct 01;35(10):1359-66
pubmed: 23024434
Sleep. 2015 Aug 01;38(8):1285-95
pubmed: 26118560
Arq Neuropsiquiatr. 2009 Dec;67(4):995-1000
pubmed: 20069207
Sleep. 2012 Aug 01;35(8):1071-83
pubmed: 22851803
Sleep. 2007 Aug;30(8):980-9
pubmed: 17702267
Sleep Med. 2018 Mar;43:14-18
pubmed: 29482805
Sleep Med. 2013 Aug;14(8):775-81
pubmed: 23219054
Sleep Med. 2015 Dec;16(12):1558-66
pubmed: 26299470
Hypertension. 2007 Jun;49(6):1235-41
pubmed: 17389258
Clin Neurophysiol. 2012 Jan;123(1):137-41
pubmed: 21723190
Sleep. 2021 Jul 9;44(7):
pubmed: 33512510

Auteurs

Kiran Maski (K)

Department of Neurology, Boston Children's Hospital, Boston, Massachusetts.

Emmanuel Mignot (E)

Stanford Center for Sleep Sciences and Medicine, Redwood City, California.

Giuseppe Plazzi (G)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio-Emilia, Modena, Italy.
IRCCS, Istituto delle Scienze Neurologiche, Bologna, Italy.

Yves Dauvilliers (Y)

National Reference Network for Narcolepsy, Sleep and Wake Disorders Centre, Department of Neurology, Gui de Chauliac Hospital, Montpellier, France.
University of Montpellier, INSERM Institute for Neurosciences Montpellier, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH